Chinese proprietary medicine in Singapore - Regulatory control of toxic heavy metals and undeclared drugs

被引:135
作者
Koh, HL
Woo, SO
机构
[1] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 119260, Singapore
[2] Minist Hlth, Inst Sci & Forens Med, Dept Sci Serv, Singapore, Singapore
关键词
D O I
10.2165/00002018-200023050-00001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Traditional Chinese medicine (TCM) is gaining popularity as a form of complementary and alternative medicine. Reports of efficacy of TCM are increasing in numbers. TCM includes both crude Chinese medicinal materials (plants, animal parts and minerals) and Chinese proprietary medicine (CPM) [final dosage forms]. Despite the belief that CPM and herbal remedies are of natural origin, unlike Western medicine, and are hence safe and without many adverse effects, there have been numerous reports of adverse effects associated with herbal remedies. Factors affecting the safety of herbal medicines include intrinsic toxicity, adulteration, substitution, contamination, misidentification, lack of standardisation, incorrect preparation and/or dosage and inappropriate labelling and/or advertising. Hence, new regulations on the control of CPM were enforced in Singapore with effect from 1 September 1999. These include licensing and labelling requirements, as well as control of microbial contamination. This article also reviews reports of excessive toxic heavy metals and undeclared drugs in CPM in Singapore between 1990 and 1997. The names, uses, toxic heavy metal or drug detected and the year of detection are tabulated. Information on the brand or manufacturer's name are provided whenever available. The public and healthcare professionals should be better informed of the basic concept of TCM and its usefulness, as well as the potential adverse effects associated with its use. Greater control over the safety and quality of CPM could be: achieved through good manufacturing practice, regulatory control, research, education, reporting usage of Chinese medicine las in drug history) as well as reporting of adverse events.
引用
收藏
页码:351 / 362
页数:12
相关论文
共 53 条
[1]   CHINESE HERBAL MEDICINE INDUCED ACUTE-RENAL-FAILURE [J].
ABT, AB ;
OH, JY ;
HUNTINGTON, RA ;
BURKHART, KK .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (02) :211-212
[2]  
[Anonymous], 1996, HOUDINI FX
[3]  
[Anonymous], 1995, TRAD CHIN MED REP CO
[4]  
[Anonymous], 1996, COMPLEMENTARY ALTERN, V3, P3
[5]   Safety issues with herbal medicine [J].
Boullata, JI ;
Nace, AM .
PHARMACOTHERAPY, 2000, 20 (03) :257-269
[6]  
CHAN TYK, 1994, VET HUM TOXICOL, V36, P238
[7]   Usage and adverse effects of Chinese herbal medicines [J].
Chan, TYK ;
Critchley, JAJH .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1996, 15 (01) :5-12
[8]   LEAD-POISONING FROM CONTAMINATED OPIUM [J].
CHIA, BL ;
LENG, CK ;
HSII, FP ;
YAP, MHL ;
LEE, YK .
BRITISH MEDICAL JOURNAL, 1973, 1 (3849) :354-354
[9]   ARSENIC POISONING FROM ANTI-ASTHMATIC HERBAL PREPARATIONS [J].
CHONGHAI, T ;
CHENGSIANG, S .
MEDICAL JOURNAL OF AUSTRALIA, 1975, 2 (11) :424-428
[10]  
De Smet P. A. G. M., 1993, ADVERSE EFFECTS HERB, VII